Company news

The ongoing COVID-19 pandemic continues to lead to extended lockdown measures in many countries around the world. There is uncertainty regarding the factors that are most effective at slowing the progression of this outbreak – does contact tracing, daily testing, isolation or a combination of these measures work best?  A… Read More

As the COVID-19 situation continues to evolve, Adelphi Values is taking every step to ensure the safety and wellbeing of all our staff, families, friends and communities. Our team has adapted well to the new ways of working and is adhering to the government guidelines to ensure we are doing… Read More

The Patient-Centered Outcomes team at Adelphi Values had a fantastic year in 2019. We have continued to grow and develop our team globally as we work with an increasing number of clients across a broad range of therapeutic areas. We look forward to further collaborations in 2020! Adelphi Values… Read More

Our Adelphi Values PROVE and Patient-Centered Outcomes teams, alongside our sister company Adelphi Real World (who together make up the Powerhouse), are exhibiting at ISPOR in Copenhagen from 4th-6th November 2019.  Situated at location C3-060, we’re looking forward to a great three days! The PROVE team will… Read More

At Adelphi Values PROVE we recognise that value demonstration for orphan/ ultra-orphan drugs in rare diseases requires a different focus to support successful market access. Read More

The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the Novartis-sponsored MSProDiscuss™ tool has now gone live on-line (https://msprodiscuss.com) and is available for MS clinicians to use.  This Clinician-Report discussion tool is available to help MS patients and physicians evaluate and… Read More

The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the FDA have qualified the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) as measures of the core symptoms of asthma in adults and adolescents. The FDA have highlighted that “these instruments have… Read More

We are delighted that one of our posters at ISPOR EU has been peer reviewed and nominated as an award finalist. The poster titled ‘Europe-wide spread of carbapenem-resistant bacteria: Epidemiology and disease burden’ provides an overview of antibiotic resistance, a critical global health issue which is becoming increasingly prevalent across Europe… Read More

Each Christmas, instead of sending cards in the post, we at Adelphi Group provide our colleagues, partners and associates with the opportunity to nominate a worthy cause for us to donate to on their behalf.

In 2017, we supported Unicef to help make a difference for children all over the world. Read More

Adelphi Values applauds Revance Therapeutics in their demonstration of RT002 treatment success in their Pivotal SAKURA Phase 3 Trials for Glabellar Lines. Read More

Adelphi Values | PROVE will be leading a podium presentation entitled ‘Differences in vaccine pricing between high‑income and low‑income markets’. Read More

On Friday 28th July 2017 over 50 staff from the Adelphi Group took part in a 7 Peak Challenge – a marathon 26 mile walk through the Derbyshire and Cheshire hills located close to our UK head office.  Despite the torrential rain and strong winds, everyone was proud to take part in the 9-hour hike to help raise money for two wonderful causes, The Alzheimer’s Society and East Cheshire Hospice. Read More

Adelphi Values will be presenting and exhibiting at the 22nd Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 20th‑24th May 2017 in Boston, MA, USA. Read More

Our 2016 Adelphi Group Client Seasons Greetings charity initiative for Unicef received a fantastic response from our clients and partners, resulting in wonderful donations. Read More

Adelphi Values has been invited to present at the DIA’s Advancing the Science of Study Endpoints meeting to be held in Washington DC on Dec 5 and 6.  The purpose of the meeting is to assemble health outcomes experts to examine global strategies for selecting study endpoints and the impact… Read More

Meet our team presenting and exhibiting at the 19th Annual European Congress at ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 31st October to 2nd November 2016 in Vienna, Austria. Our workshop this year is entitled ‘Measuring multiple medication adherence – which… Read More

In October, our US team will be taking part in JDRF One Walk, to raise money for the Juvenile Diabetes Research Foundation (JDRF). Covering 5km around Boston, the JDRF flagship event aims to raise awareness of type1 diabetes (T1D), and funds toward achieving their mission, “to create a world without… Read More

The Institute of Pharmaceutical Medicine at the University of Basel invited Bryan Bennett from Adelphi Values to give a lecture to students of the post-graduate ‘European Course of Pharmaceutical Medicine’, a course which is typically undertaken by pharmaceutical industry professionals. The lecture titled ‘Epidemiology and patient-reported outcome studies’ was part… Read More

Thanks to all our clients and colleagues who visited our exhibition stand at ISPOR US which took place in Washington DC. As a result of your support, we have donated $500 to JDRF this year’s chosen charity. JDRF is a charitable organisation that supports sufferers and families… Read More